Inhaled antibiotic shows promise for ventilator lung infections
NCT ID NCT07369336
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding an inhaled antibiotic (amikacin) to standard treatment helps ICU patients recover faster from ventilator-associated pneumonia. Researchers tracked how quickly the infection cleared, how long patients needed the ventilator, and any side effects. The trial included 90 adults aged 18-80 who were on ventilators and diagnosed with VAP.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA (VAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lahore General Hospital
Lahore, Punjab Province, 54000, Pakistan